Side-by-side comparison of AI visibility scores, market position, and capabilities
NYSE: AXP global closed-loop premium payment network at $65.9B FY2024 revenue with $1.19T transaction volume; Berkshire Hathaway holding competing with Visa and Chase Sapphire for premium consumer and corporate cards.
American Express Company is a New York-based global financial services company — listed on NYSE (NYSE: AXP) and a Berkshire Hathaway top holding — operating a closed-loop payment network that integrates card issuance, merchant acquiring, and rewards processing in a single platform serving premium consumers, small businesses, and corporations with charge cards, credit cards, corporate expense management, and travel services. American Express generated $65.9 billion in total revenue in fiscal year 2024 (+8.98% year-over-year), with $1.19 trillion in US cardmember purchase volume (11.1% market share by purchase volume versus Visa's 61.1% and Mastercard's 25.8%), serving 53.8 million total cards-in-force worldwide including the Platinum Card, Gold Card, Green Card, and Centurion (Black) Card product lines.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.